Search Results
Blinatumomab consolidation therapy for DLBCL
Blinatumomab for consolidation and maintenance in ALL
Optimizing blinatumomab for B-ALL
Blinatumomab plus ponatinib for Ph+ ALL
Blinatumomab and inotuzumab in children with R/R B-ALL
Current treatment landscape of DLBCL
Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lym...
Satellite Symposium | Sequencing treatment options in primary refractory DLBCL
Unmet needs for radiotherapy in lymphoma
Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in HR/IR First Relapse of B-ALL
Perspectives on Novel Antibody Platforms in DLBCL
IELSG30: treating primary testicular DLBCL
